Loading...

Chinese Journal of Blood Purification

    12 January 2014, Volume 13 Issue 01 Previous Issue    Next Issue
    The clinical applications of long- acting and short- acting erythropoietin in hemodialysis patients
    2014, 13 (01):  1-4.  doi: 10.3969/j.issn.1671-4091.2014.1.001
    Abstract ( 311 )   HTML ( 0 )   PDF (449KB) ( 503 )  
    Objective To observe the efficacy of the long- acting erythropoietin (Maxim Luo) and the short- acting erythropoietin β (LUO Man) in the treatment of anemia in maintenance hemodialysis patients, and to evaluate and compare the safety and tolerability between the two preparations. Method We recruited the hemodialysis patients who met the inclusion criteria and were treated in the Blood Purification Center of Guangdong General Hospital during the period from February 2008 to May 2010. They were randomly divided into two groups, the long-acting group, in which patients were intravenously administrated with Maxim Lo beginning from 0.4 μg/kg and once every two weeks, and the short acting group, in which patients were intravenously administrated with LUO Man 40 IU/kg three times a week. The study lasted for 55 weeks, including screening period for 2 weeks, correction period for 16 weeks, evaluation period for 8 weeks, and extension period for 28 weeks. The last follow-up was conducted at the 53th week. Hemoglobin concentration difference, hemoglobin response rate, and hemoglobin concentration change against basal value were evaluated at the 24th week, and safety and tolerability were compared between the 2 groups at the 53th week. Results Twenty- two patients (11 cases in each group) were enrolled in this study. The response rate to the treatment was 82% (9/11) in both groups. Hemoglobin change at the 24th week was statistically insignificant between the two groups. Hemoglobin response rate at the 53th week was 81% (19/22) in the 22 patients, with the rate of 72% (8/11) in long acting group and 100% (11/11) in short acting group. Analysis of variance to the repeated measurements showed that hemoglobin concentration change and adverse events were statistically insignificant between the two groups. Conclusion The therapeutic effect was similar between long-acting erythropoietin and short-acting erythropoietin β. Both preparations are well tolerated and effective for erythropoiesis. Either long-acting or short-acting erythropoietin can be used clinically according to patient’s situation.
    Metrics
    The analysis of factors associated with anemia in hemodialysis patients
    2014, 13 (01):  5-7.  doi: 10.3969/j.issn.1671-4091.2014.1.002
    Abstract ( 320 )   HTML ( 1 )   PDF (324KB) ( 240 )  
    Objective To investigate the prevalence of anemia and the factors relating to anemia for the management of anemia and improvement of life quality in maintenance hemodialysis (MHD) patients. Methods Patients on MHD for more than 3 months in this hospital in March 2012 were recruited and observed. Their clinical and biochemical parameters were collected. Results A total of 384 patients (194 males and 190 females) with the mean dialysis age of 42.22±38.26 months were enrolled in this study. Hemoglobin (Hb) lower than the range of Hb suggested by KIDGO guideline was found in 247 patients. Urea nitrogen reduction ratio, Kt/V, blood pressure, serum K+, Ca2+, P and LDL were similar in patients with lower Hb and those with normal Hb (P>0.05), but ALB (P=0.012), iron (P=0.018), ferritin (P =0.024), creatinine (P=0.018), uric acid (P=0.012), intact parathyroid hormone (P=0.006), alkaline phosphatase (P=0.044) were correlated to anemia. Multiple linear regression analysis found that female, lower iron concentration, and higher ferritin, intact parathyroid hormone and alkaline phosphatase were associated with lower Hb. Conclusion Maintenance of normal iron metabolism and control of secondary parathyroidism are essential to MHD patients. Whether the target Hb value should be identical in both genders is currently unknown yet, and large cohorts of MHD patients are required to understand this issue.
    Metrics
    Impact of high-flux hemodialysis on serum hepcidin and its relative factors
    2014, 13 (01):  8-11.  doi: 10.3969/j.issn.1671-4091.2014.1.003
    Abstract ( 274 )   HTML ( 0 )   PDF (333KB) ( 437 )  
    Objective To investigate the change of serum hepcidin in patients after switching from maintenance hemodialysis (MHD) to high- flux hemodialysis (HFD), and to analyse its related factors. Methods Forty MHD patients were enrolled. They were then changed to HFD for 12 months. Serum hepcidin, blood indices of iron metabolism, anemia and inflammation (high sensitivity C- reactive protein, hs- CRP) were assayed at 0 month, 2 months, 6 months and 12 months after the switching. Pearson correlation and multiple stepwise regression methods were used to analyze the relationship between serum hepcidin and these indices. Results Serum hepcidin levels after the switching for 2, 6 and 12 months were significantly higher than the level at 0 month (P<0.01). Changes of ferritin and hs-CRP were consistent with the change of serum hepcidin. Pearson correlation analysis showed that serum hepcidin was positively correlated with serum iron (r= 0.164, P<0.05), transferrin saturation (r=0.168, P<0.05), ferritin (r=0.173, P<0.05), hs-CRP (r=0.204, P< 0.01) and β2- microglobulin (r=0.692, P<0.01). Multiple stepwise regression showed that transferrin saturation, hs-CRP, hemoglobin and β2-microglobulin levels were closely related to serum hepcidin level in HFD patients. Conclusions Serum hepcidin can reflect the iron storage in the body. Microinflammatory state is a key factor affecting hepcidin expression in hemodialysis patients. HFD may improve the iron metabolism status in MHD patients. Microinflammatory status is the important factor that influences the improvement processes.
    Metrics
    Hemoglobin Variability is associated with Mortality in patients on maintenance hemodialysis
    2014, 13 (01):  12-16.  doi: 10.3969/j.issn.1671-4091. 2014.01.004
    Abstract ( 249 )   HTML ( 2 )   PDF (521KB) ( 205 )  
    Objective To determine the relationship between hemoglobin variability and mortality in maintenance hemodialysis (MHD) patients. Methods A total of 364 MHD cases were recruited from Shanghai Renal Registry Network. The relationship between hemoglobin variability and all-cause mortality was assessed. Results In the 364 MHD cases, the average age was 63.07±13.93 years, the dialysis vintage was 76.0 (42.25, 134.0) months, and 85 patients (23%) died. The dead patients had a higher mean hemoglobin SD and CV comparing with the survival patients (19.19±6.31 vs. 13.74±5.89, and 0.172±0.07 vs. 0.126±0.056, respectively, P<0.001). Risk of all- cause mortality in patients in the upper quartile (P75) of hemoglobin SD was significantly higher than those in the lower quartile (P25) (OR=5.964, 95% CI 2.663~13.357, P<0.001), even after adjustment for demographic data, lifestyle factors and biochemical markers (OR=4.961, 95% CI 1.959~11.238, P<0.001). Kaplan-Meier method showed that patients with hemoglobin SD and CV in the upper quartile had a lower survival rate (P<0.001). ROC-AUC of hemoglobin SD and CV for all-cause mortality were 0.677 and 0.721, respectively (cutoff 10.647g/l and 0.1086, respectively; accuracy 89.4% and 85.1%, respectively; specificity 67.7% and 60.3%, respectively; P<0.001). Multivariate logistic regression analysis showed that higher hemoglobin CV, older age and higher CRP were the independent risk factors for all-cause mortality. Conclusions The highest hemoglobin SD and CV were independently correlated with all- cause mortality. Hemoglobin variability may have prediction value for mortality in MHD patients.
    Metrics
    Study on correlation between carotid intima-media thickness with serum HsCRP, FGF23 and Klotho protein in maintenance hemodialysis patients
    2014, 13 (01):  17-22.  doi: 10.3969/j.issn.1671-4091.2014.1.005
    Abstract ( 245 )   HTML ( 2 )   PDF (410KB) ( 179 )  
    OBJECTIVE To understand the clinic feature of the maintenance hemodialysis(MHD) patients with carotid artery atherosclerosis, analyze the relationship between carotid intima-media thickness(CIMT) and serum high sensitive c-reactive protein(HsCRP), fibroblast growth factor 23(FGF23), Klotho protein levels. METHODS 88 MHD patients were enrolled in the blood purification center, Beijing Hospital of the Ministry of Health, from January to June 2012. The patients were divided into CIMT thickening group and the CIMT normal group based on their carotid color Doppler ultrasound results. FGF23 and Klotho protein were detected by using double antibody sandwich enzyme-linked immunosorbent assay (ELISA). Possible risk factors of CIMT thickening, such as age, gender, duration of dialysis, diabetes, combination therapy, FGF23, Klotho protein, hsCRP, lipids were analyzed and compared between the two groups, while non-conditional logistic regression were used for multivariate analysis to determine the risk factors for CIMT thickening. RESULTS Among the 88 MHD patients, increased CIMT was found in 53 patients(60.2%), while the remaining 35 patients (39.8%) had normal CIMT. The median of the two sets of CIMT were 1.5mm and 1.0mm respectively, and the difference between the two groups was statistically significant(P=0.000). The incidence of atherosclerotic plaque in the group with increased CIMT was significantly higher than the group with normal CIMT(92.5% vs.65.7%,P=0.001). Univariate analysis indicated that the average age of the CIMT thickened group was 66.64±10.61 years, and the average age of the group with normal CIMT was 58.63±11.78 years, the difference was statistically significant(t=3.320,P=0.001); Diabetes prevalence of the CIMT thickened group was 37.7%, Diabetes prevalence of the group with normal CIMT was 17.1%, the difference was statistically significant( =4.294,P=0.038); The median of the two sets of FGF23 were 127.82 ng/L and 86.74 ng/L respectively, the difference was statistically significant(Z=-3.713,P=0.000); The median of the two sets of HsCRP were 5.34mg/L and 2.19mg/L respectively, the difference was statistically significant(Z=-3.547,P=0.000); The median of the two sets of Klotho protein were 42.48 U/L and 41.21 U/L respectively, the difference was not statistically significant(Z=-0.085,P=0.932). Non-conditional logistic regression analysis showed that age, FGF23 and hsCRP were independent risk factors for CIMT thickening in MHD patients, OR values were 1.061 (1.007,1.118), 1.016 (1.003,1.028), 1.344 (1.115,1.621), respectively. CONCLUSION Thickened CIMT are prone to have more atherosclerosis plaque with MHD patients . Serum HsCRP, FGF23 and age are independent risk factors for CIMT thickening in MHD patients.
    Metrics
    Effects of a parathyroidectomy on health-related quality of life in uremic patients with secondary hyperparathyroidism
    2014, 13 (01):  23-26.  doi: 10.3969/j.issn.1671-4091.2014.1.006
    Abstract ( 277 )   HTML ( 0 )   PDF (325KB) ( 285 )  
    【Abstract】Objective To observe the effect of a parathyroidectomy on health-related quality of life in uremic patients with secondary hyperparathyroidism. Methods Thirty uremic patients under hemodialysis therapy receiced a parathyroidectomy for secondary hyperparathyroidism.They were prospectively studied the serum calcium(Ca),phosphorus(P),the product of calcium and phosphorus(Ca×P),parathyroid(iPTH) before and 1 year after parathyroidectomy. Throughout the follow-up period, all subjects completed the Kidney Disease Quality of Life Short Form-36 (KDQOL SF-36) questionnaire at before and 1 year after parathyroidectomy. Results Serum levels of iPTH,calcium,phosphorus and Ca×P were lower at 1 year after treatment compared with that before parathyroidectomy (tiPTH=-9.563,P=0.000,tp=-5.994,P=0.000,tca×p=-7.197,P=0.000,tca= -4.928,P=0.000). SF-36(61.3±19.6 VS 51.2±24.5, t=2.456,P=0.021) and overall health rating(OHR,73.8±11.1VS 65.8±15.2, t=2.699,P=0.012) of our study were increased at one year after parathyroidectomy.There were significant improvement among physically associated problems such as physical function(PF, 56.5±27.0 VS 51.8±32.1,P<0.05)、role-physical(RP, 48.2±41.9 VS 28.5±40.1,P<0.05)、bodily pain(BP, 66.1±26.7 VS 53.6±27.9,P<0.05)、general health(GH, 50.4±22.1 VS 40.6±23.6,P<0.05)、symptom/problems(SP,85.8±10.5VS 73.8±11.1, P<0.05)、effects of kidney disease(EKD,77.1±16.6 VS 65.3±20.7,P<0.01) and sleep (75.1±23.0 VS 58.9±24.5, P<0.01). Conclusion Parathyroidectomy could improve health-related quality of life among hemodialysis patients with secondary hyperparathyroidism.
    Metrics
    Factors affecting long-term survival of tunneled cuffed hemodialysis catheters
    2014, 13 (01):  41-45.  doi: 10.3969/j.issn.1671-4091.2014.01.011
    Abstract ( 510 )   HTML ( 1 )   PDF (513KB) ( 297 )  
    Objective To evaluate the factors affecting long- term survival of tunneled cuffed venous catheters (TVCs) in hemodialysis patients. Two different catheters, HemoSplit (Bard) and Permcath (Quinton) were used in this study. Methords Kaplan-Meier survival analysis with log- rank test was used to compare the effect of various factors on catheter survival. Cox regression analysis was performed to determine the relative importance of various factors. Results First, second or subsequent catheterizations had no effect on catheter survival. Age and sex also did not significantly affect catheter survival. Catheter survival was longer in right internal jugular vein indwelling catheterization and non-diabetic patients. HemoSplit catheter was better than Permcath catheter in catheter survival. Cox proportional hazard modelling demonstrated that diabetes and the vein the catheter indwells in were the independent factors for catheter survival. Conclusion Primary diseases and the vein for catheterization significantly affect catheter survival. These factors should be considered before the surgery.
    Metrics
    Analysis of the factors relating to catheter infection in hemodialysis patients with temporary central vein catheterization
    2014, 13 (01):  46-48.  doi: 10.3969/j.issn.1671-4091.2014.01.012
    Abstract ( 232 )   HTML ( 0 )   PDF (306KB) ( 278 )  
    Objective To explore the factors relating to catheter infection in hemodialysis patients with temporary central vein catheterization. Methods Eighty- two hemodialysis patients with temporary central vein catheter and treated in the period of February to December 2012 in our hospital were retrospectively surveyed.
    Patients were divided into several groups according to position of the catheter, diabetes, nutrition indicators (hemoglobin and albumin), age and eGFR. Their catheter infection rate was investigated. Results The catheter infection rate was higher in femoral vein (28.8%) than in internal jugular vein ( 6.7%; χ2=5.695, P<0.05),  and was higher in patients with diabetes (33.3%) than those without diabetes (12.2%; χ2 =5.336, P< 0.05). The catheter infection rate was also influenced by the nutrition indicators of hemoglobin and albumin (P<0.05), but not by age and eGFR of the patients (P>0.05). Conclusions Catheter infection in hemodialysis patients with temporary central vein catheterization was related to position of the catheter, diabetes and nutrition indicators (hemoglobin and albumin). These factors should be taken into consideration to prevent catheter infection in hemodialysis patients with temporary central vein catheterization.
    Metrics
    Preliminary study of balloon angioplasty in patients with venous hypertension associated with autogenous arteriovenous fistula.
    2014, 13 (01):  49-51. 
    Abstract ( 203 )   HTML ( 0 )   PDF (276KB) ( 324 )  
    Objective To prospectively evaluate the efficacy of balloon angioplasty(BAP) in patients with venous hypertension associated with autogenous arteriovenous fistula(AVF). Methods 24 patients with venous hypertension associated with AVF were hospitalized between June 2010 and December 2011 in the Department of Nephrology of West China Hospital of Sichuan University. 15 of them who received BAP were recruited. The clinical characteristics, locations of the lesion and therapeutic effects were summarized. Results There were 15 patients (11 males and 4 females) recruited in our study with the mean age of (58.24±10.14) years. Central venous stenosis, obstruction or thrombosis was confirmed in all of them via computerized topographic angiography (CTA) or color Doppler ultrasound (CDU). DSA-guided balloon angioplasty (BAP) were then performed, 13 cases were successful while 2 other cases ended with failure because the guide wires cannot pass through the obstructed central venous. The symptoms were resolved after 2 days on average following BAP. Followed up for 7~24 months, 12 cases maintained clinical remission, and the AVFs were functional. Only one patient got a restenosis after 17 months later. Conclusions The preliminary results demonstrate that BAP for venous hypertension associated with AVF appears to be effective and safe. Further follow-up of patients is required to determine the long-term outcomes.
    Metrics
    Analysis of dialysis discontinuation and palliative care in maintenance hemodialysis patients by means of dialysis
    registration system
    2014, 13 (01):  55-58.  doi: 10.3969/j.issn.1671-4091.2014.01.015
    Abstract ( 205 )   HTML ( 0 )   PDF (226KB) ( 373 )  
    Objective This retrospective and observational study was carried out to analyze the incidence of dialysis discontinuation and the related palliative care in maintenance hemodialysis (MHD) patients. Methods We retrospectively evaluated the patients who died in Pu-Xi Dialysis Unit of Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China from Jan. 1, 1998 to Dec. 31, 2012. Their sex, age, dialysis age, and primary disease were compared between dialysis discontinuation group and non-discontinuation group. We also collected the information about cause of death and related palliative care. Results A total of 115 MHD patients (male 69 and female 46; mean age 64.6±14.2 years old; mean dialysis age 5.4 years) who died in this period were analyzed. The major causes of renal failure were chronic glomerulonephritis (27.8%), hypertensive nephrosclerosis (23.5%), and diabetic nephropathy (12.2%). The most common cause of death was cerebrovascular accident (39.1%), followed by sepsis (15.7%), cardiocerebral events (10.4%), sudden death (8.7%), and advanced cancers (8.7%). Of the 9 patients (8%) discounting dialysis, 2 were females and 7 were males, and the median living interval after dialysis discontinuation was only 8.1 days. The causes of dialysis continuation included advanced cancers (4 cases), severe infection (one case), cerebral accident (one case), technical difficulties in dialysis (one case), and financial problems (2 cases). Support measures were given to all of the 9 patients after dialysis discontinuation. Conclusions Dialysis registration system is useful for the analysis of patients discounting dialysis. In this series of patients, 8% patients discontinued their dialysis, much lower than the ratio in developed countries. The major cause of death in the patients discounting dialysis was advanced cancers.
    Metrics